UK markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.80-0.14 (-1.76%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
30/06/2017
Total revenue
1,650
4,046
9,862
4,159
8,900
Operating expenses
Research development
28,394
19,863
14,540
17,275
28,300
Selling general and administrative
19,156
15,202
6,187
6,681
5,700
Total operating expenses
47,550
35,065
20,727
23,956
36,300
Operating income or loss
-45,900
-31,019
-10,865
-19,797
-27,400
Interest expense
1,849
1,874
2,388
2,680
1,800
Total other income/expenses net
899
836
-5,051
4,521
100
Income before tax
-46,807
-31,982
-18,155
-17,898
-29,100
Income tax expense
123
238
490
109
300
Income from continuing operations
-46,930
-32,220
-18,645
-18,007
-29,400
Net income
-46,930
-32,220
-18,645
-18,007
-29,400
Net income available to common shareholders
-46,930
-32,220
-18,645
-18,346
-29,400
Basic EPS
-
-0.36
-0.86
-2.90
-8.36
Diluted EPS
-
-0.36
-0.86
-2.90
-8.36
Basic average shares
-
88,296
21,570
6,316
3,513
Diluted average shares
-
88,296
21,570
6,316
3,513
EBITDA
-
-27,398
-12,171
-12,015
-27,200